Pupose:In order to develop a treatment for recessive retinitis pigmentosa the ultimate objective is to introduce a normal copy of the abnormal gene into photoreceptors. The post-mitotic status of photoreceptor cells make them unsuitable targets for existing retroviral vectors. One of the strategies that we have been exploiting is adenoviral (AV) mediated gene transfer. Here we report successful transduction of ocular tissues including neuroretina and retinal pigment epithelium (RPE) with a IacZ reporter gene using an adenoviral vector. Methods:The recombinant adenovirus, pXCXRBb. contains an E.Coli Bgalactosidase gene driven by a Rous Sarcoma virus promotor and with SV40 polyadenylation signals. Approximately 0.4~1 of viral suspension containing pXCXRBb at 109 pfo/ml was injected with a 1.5 cm, 34-gauge hypodermic needle into the vitreous and into the subretinal space of HsdOla:MFl mice. Control MFI and BALB/cOlaHsd eyes were injected with an equivalent volume of PBS. Animals were perfused 4,7 and 14 days postinjection with 2% pamformaldehyde and 0.05 46 glutaraldehyde in O.lM phosphate buffer. The eye cups were incubated at room temperature with X-gal overnight to detect lacZ activity (blue staining) in transduced cells. The tissue was paraffin embedded and sectioned at 5-10 pm thickness. Sections were counterstained with nuclear fast red and examined by light microscopy. Results and Conclusion:Fine blue staining of the RPE and of iris-and ciliary body epithelium was observed in BALB/c controls indicating endogenous B-gal activity which makes evaluation of transduction after intravitreal injections difficult in these mice. This was not seen in control MFI mice which we therefore used in our subsequent experiments. Distinct B-gal staining of RPE cells, photoreceptor cells and optic nerve glia cells was only detected in injected eyes and abundant near the injection site. Over time. the percentage of IacZ-positive cells decreased and is highest during the first week post injection. Whether thts is due to an immune response against cell transduced by the AV vector remains to be determined by ongoing experiments. Our results to date suggest that the current generation of replication deficient adenoviral vectors may be a tool of limited use for gene transfer into the retina. However, this work will serve as a baseline for further development of gene therapy of RF' for which application of a non pathogenic, integrating DNA vector such as adeno associated virus with a photoreceptor cell specific promotor may have higher potential. Purpose: Mutations in the IJ-PDE, peripherin-rds and rhodopsin gene cause retinal dewneration in mice as well as humans. The fact that apoptosis is the final pa&way in each of the different mouse phenotypes s;g&sts that a common mechanism is involved.
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The turnour suppressor gene ~53 is involved in various apoptotic pathways in the mouse kye inch&g apoptosis in the developing lens and apoptosis due to the viral proteins, human papillomavirus -16 E7 and adenovirus EIA. The aim of this experiment is to elucidate the role of pS3 in the apoptosis seen in rds mice. We therefore generated animals that were deficient in the ~53 gene and homozygous for the rds mutation. Fls -all double heterozygotes (p+/r+)-were intercrossed and the F2 offspring were genotyped by PCR from tail DNA. Mice were sacrificed at 2 months and their eyes examined histologically.
Semi-thin sections were taken at the optic nervehead level and subsequent nuclear counts and measurement of the thickness of the different retinal layers were used to asses morphological differences.
Results and Conclusion: At 2 months the degeneration in an rds mouse is about 50% complete with the photoreceptor cell layer being reduced to half its thickness.
Analysis of mice at 2 months carrying the pp/rr genotype showed similar degeneration to that of p+lrr and ++/rr siblings and the original rds parent. Our results to date suggest that retinal degeneration in the rds mouse occurs via an apoptotic pathway that is ~53 independent. This is to be confirmed by agarose gel electrophoresis to detect apoptosis-specific intemucleosomal DNA fragmentation. To perform clinical and DNA research in a large pedigree with autosomal recessive retinitis pigmentosa (arRP). Ec!aimb A large pedigree from a genetic isolate in the Netherlands, with 45 affected persons with arRP, was examined ophthahnologically. Blood samples were collected for DNA analyses. Fi&u!t3 Initially, the arRP pedigree suggested the occurrence of one type of RP with one single gene. Extensive clinical examination revealed different phenotypes: 22 patients showed RP with preserved para-arteriolar retinal pigment e&helium (PPRPE), 5 showed retinitis punctata albesceru, 4 RP with geographic atrophy of the macula, 2 pericentral retinal dystrophy, and 12 had Usher's syndrome (type II). DNA linkage analysis and genetic homogeneity analysis resulted in the assignment of one gene for RP with PPRPE to chromosome lq31-32.1. and the presumption that at least one more gene is likely to segregate in this pedigree. Conclusion The phenotype and genotype of autosomal recessive RP is, even within a single large family, more heterogeneous than previously anticipated in the literature.
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